Regeneron Pharmaceuticals Inc. stock rises Thursday, outperforms market

Shares of Regeneron Pharmaceuticals Inc. REGN, +1.88% rallied 1.88% to $823.81 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +0.38% rising 0.38% to 4,567.80 and the Dow Jones Industrial Average DJIA, +1.47% rising 1.47% to 35,950.89.

This was the stock's third consecutive day of gains.

Regeneron Pharmaceuticals Inc. closed $30.16 below its 52-week high ($853.97), which the company achieved on October 13th.

The stock outperformed some of its competitors Thursday, as Amgen Inc. AMGN, +1.14% rose 1.14% to $269.64, Moderna Inc. MRNA, -1.66% fell 1.66% to $77.70, and Gilead Sciences Inc. GILD, +1.82% rose 1.82% to $76.60.

Trading volume (940,243) eclipsed its 50-day average volume of 439,659.

Editor's Note: This story was auto-generated by Automated Insights , an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.